The strength of our study is that it is the first to demonstrate an association between FSH and MetS and obesity, lipid profile, blood pressure, insulin resistance, and adipokines, which are commonly known metabolic risk factors. This evidence concerns the gene BRD2 and obesity due to melanocortin 4 receptor deficiency.